Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC25A15P5 is a **processed pseudogene** in humans, derived from the solute carrier family 25 member 15 gene (SLC25A15), which encodes a mitochondrial ornithine transporter[1][5][7][10][11]. Unlike its parent gene, SLC25A15P5 does not produce a functional protein and is annotated as a non-functional genomic element[7][9][10][11]. Pseudogenes like SLC25A15P5 are typically the result of retrotransposition events and generally do not participate in known biological processes or serve as direct therapeutic targets[4]. There are no documented interacting drugs, clinical biomarkers, or disease associations for SLC25A15P5.\n\nKey Notes:\n- This entry is a pseudogene, not a protein-coding gene[7][10].\n- It is not a therapeutic target.\n- If you are seeking information about ornithine transporter function or disease roles related to mitochondrial transport, refer to the parent gene (**SLC25A15**) instead[8].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 25 member 15 pseudogene 5 (SLC25A15P5).